-transparent.png){kind=logo}
The concentration of the leukotrienes B4 (LTB4) and C4 (LTC4) was measured in the cerebrospinal fluid (CSF) of 38 multiple sclerosis (MS) patients and 51 with other neurological diseases. The LTB4 and LTC4 levels were significantly elevated in MS compared with the controls. The findings suggest that lipoxygenase products might play a pathogenetic role in the early, encephalitogenic phase of MS. The administration of lipoxygenase inhibitors or leukotriene antagonists might well open new perspectives for the treatment of MS.
Related Publications
I Neu, and
J Mallinger, and
A Wildfeuer, and
L Mehlber
April 1997,
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego,
I Neu, and
J Mallinger, and
A Wildfeuer, and
L Mehlber
January 2019,
Frontiers in immunology,
I Neu, and
J Mallinger, and
A Wildfeuer, and
L Mehlber
January 1950,
Research publications - Association for Research in Nervous and Mental Disease,
I Neu, and
J Mallinger, and
A Wildfeuer, and
L Mehlber
March 1974,
Rinsho shinkeigaku = Clinical neurology,
I Neu, and
J Mallinger, and
A Wildfeuer, and
L Mehlber
August 2003,
Nihon rinsho. Japanese journal of clinical medicine,
I Neu, and
J Mallinger, and
A Wildfeuer, and
L Mehlber
January 1994,
Clinical neuroscience (New York, N.Y.),
I Neu, and
J Mallinger, and
A Wildfeuer, and
L Mehlber
October 2009,
Annals of Indian Academy of Neurology,
I Neu, and
J Mallinger, and
A Wildfeuer, and
L Mehlber
September 1976,
Missouri medicine,
I Neu, and
J Mallinger, and
A Wildfeuer, and
L Mehlber
January 1982,
Acta medica Iugoslavica,
I Neu, and
J Mallinger, and
A Wildfeuer, and
L Mehlber
December 1990,
Molecular and chemical neuropathology,
